soul trial oral semaglutide cardiovascular outcomes results 2025 nejm

soul trial oral semaglutide cardiovascular outcomes results 2025 nejm 2024 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial semaglutide soul trial oral cardiovascular

Name: soul trial oral semaglutide cardiovascular outcomes results 2025 nejm 2024 Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial semaglutide soul trial oral cardiovascular
Brand: actil.am
SKU: 38305915016
Price: 23.27 USD
Availability: InStock
Rating: 4.0522 (7 reviews)

SKU: 38305915016

4.1

USD23.27 USD45.27

Pay in 4 interest-free payments of $5.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

GLP-1 receptors are present on cardiomyocytes, endocardium, microvascular endothelium, and coronary smooth muscle cells [10.0]

The need to change how you eat is real

In contrast, Beta-1 receptors are mainly distributed in the heart, and can increase myocardial contractility, self-regulation, and conduction function